• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Boston hosts Biopharm America

Boston hosts Biopharm America

September 15, 2015
CenterWatch Staff

Biopharm America, which is designed to spur strategic relationships by way of a Web-based service that sets up face-to-face meetings and more, kicks off today in Boston with more than 450 companies, 680 delegates and 770 licensing opportunities on the roster.

“It’s real important to be doing touch-base and updates with pharma all the time, and with other biotechs,” Douglas MacDougall, president of MacDougall Biomedical Communications, told BioWorld Today, and the timing of Biopharm makes for “good grounding” among the other events he tells his clients not to miss: the Biotechnology Industry Organization (BIO) annual convention, the J.P. Morgan Healthcare Conference and BIO Europe.

The Biopharm event, produced by the partnering firm EBD Group and MassBio, a trade organization for the Massachusetts biotech industry, features panel talks, company presentations and an exhibition hall. New this year is the Biotech Startup Day on Wednesday, during which participants can meet up, in an interactive format, with early-stage companies and nascent projects that have been vetted by a committee of scouts from top pharma companies.

Another new feature is Partnerships in Regenerative Medicine and Advanced Therapies Day on Thursday, with programs that EBD said are designed to bring together "key players in this game-changing paradigm in human health.”

For the fifth year, MacDougall brings to Biopharma his popular pitch session, wherein audience members are given 30 seconds to sell their ideas or products to a lineup of judges from the biopharma industry, with a winner declared at the end.

The plenary session will deal with the growing phenomenon of heavy hitters leaving big corporations to lead small companies. It is being moderated by Evercore Partners Senior Managing Director Francois Maisonrouge, who will be joined by Deborah Dunsire, president and CEO of FORUM Pharmaceuticals; Jeffrey Kindler, CEO of Centrexion Corp.; Jeremy Levin, chairman and CEO of Ovid Therapeutics; and Christopher Viehbacher, managing partner with Gurnet Point Capital. All five, after stints with big pharma, joined innovative, less-established firms.

About 73% of Biopharm attendees originate are from the U.S., with 21% from Europe and 6% from Asia. Roughly 32% are from the biotech sector, with 20% from pharma, 17% from professional services such as consulting and law, 12% each from finance and biotech research and development, and 7% in the “other” category, including government agencies and the media. Many (42%) are senior management, with 34% described as top management and 24 percent middle management.

The Biopharm event runs through Thursday.

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing